What Researchers Did
Researchers treated a single patient with Parkinson's disease, severe depression, and anxiety using hyperbaric oxygen therapy for 30 days.
What They Found
After 30 days of hyperbaric oxygen treatment, the patient showed improvements in clinical assessment scores for depression and anxiety. These improvements were noted across the Unified Parkinson's Disease Rating Scale I and II, Hamilton Depression Rating Scale, and Hamilton Anxiety Rating Scale.
What This Means for Canadian Patients
For Canadian patients with Parkinson's disease experiencing severe depression and anxiety, especially those unable to use standard medications like dopaminagonists or SSRIs, this case suggests hyperbaric oxygen therapy might offer a new treatment avenue. It could potentially help manage these challenging psychiatric symptoms.
Canadian Relevance
No direct Canadian connection identified. This study does not cover a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
As a single case report, this study's findings cannot be generalized to a wider population of Parkinson's disease patients.